Explore more publications!
Louisiana Health Daily
Got News to Share?

Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 19, 2025

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
November 19, 2025

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

Indeterminate GlobeNewswire
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
November 19, 2025

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

Indeterminate GlobeNewswire
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
November 19, 2025

Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire
Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation
November 19, 2025

Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation

Indeterminate GlobeNewswire
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
November 19, 2025

Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
November 19, 2025

Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery

Indeterminate GlobeNewswire
Cellectis publie un article dans Nature Communications sur un procédé d’édition génomique non viral efficace pour l’insertion génique dans les cellules souches hématopoïétiques
November 19, 2025

Cellectis publie un article dans Nature Communications sur un procédé d’édition génomique non viral efficace pour l’insertion génique dans les cellules souches hématopoïétiques

Indeterminate GlobeNewswire
Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for Employees Residing in Japan
November 19, 2025

Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for Employees Residing in Japan

Indeterminate GlobeNewswire
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
November 19, 2025

Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions